Androgen receptor activity in T cells limits checkpoint blockade efficacy

Nature, Published online: 23 March 2022; doi:10.1038/s41586-022-04522-6

. Androgen-receptor blockade can overcome immunotherapy resistance in prostate cancer by intrinsically enhancing T cell function and IFNγ responses.

Comments

Popular posts from this blog

Photo Of The Day By Valerie Millett